Department of Experimental Clinical Oncology

Error in site JavaScript
Untitled Document

PUBLIKATIONER 1990

 

144.      Andersen, J., Thorpe, S., King, W.J., Rose, C., Christensen, I., Rasmussen, B.B. & Poulsen, H.S.: The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assays. Eur. J. Cancer 26: 442-449, 1990.

145.      Andersen, J., Thorling, K., Bentzen, S.M., Brincker, H., Christensen, B.E. & Pedersen, M.: Phase III trial of cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) versus cis-platin, etoposide, bleomycin and prednisone (CisEBP) for the treatment of advanced non-Hodgkin's lymphomas of high grade malignancy. Acta Oncologica 29: 995-999, 1990.

146.      Bentzen, S.M., Balslev, I., Pedersen, M., Teglbjærg, P.S., Hanberg-Sørensen, F., Bone, J., Jacobsen, N.O., Overgaard, J., Sell, A., Bertelsen, K., Hage, E., Fenger, C., Kronborg, O., Hansen, L., Høstrup, H. &  NørgaardPedersen, B.: Blood transfusion and prognosis in Dukes' B and C colorectal cancer. Eur. J. Cancer 26: 457-463, 1990.

147.      Bentzen, S.M. & Thames, H.: Isoeffective doses. (Letter to the editor). Brit. J. Radiology 63: 82, 1990.

148.      Bentzen, S.M., Thames, H.D. & Overgaard, J.: Does variation in the in vitro cellular radiosensitivity explain the shallow clinical dose-response curve of malignant melanoma. Int. J. Rad. Biol. 57: 117-126, 1990.

149.      Bentzen, S.M., Thames, H.D. Tucker, S.L. & Smith, C.: New options in direct analysis of dose-response data. Int. J. Rad. Biol. 57: 221-225, 1990.

150.      Bentzen, S.M., Turresson, I. & Thames, H.D.: Fractionation sensitivity and latency of telangiectasia after postmastectomy radiotherapy. A graded-response analysis. Radiotherapy and Oncology 18: 95-106, 1990.

151.      Brünner, N., Poulsen, H.S. & Clarke, H.S.: Effect of oophorectomy on estrogen and progesterone receptor concentrations in an ovarian-dependent and ovarian-independent human breast cancer grown in nude mice. In: Immune-deficient animals in experimental medicine. (eds.: Wu, B-q & Zheng, J) Karger, Basel pp. 196-201, 1990.

152.      Chaplin, D.J., Horsman, M.R. & Trotter, M.J.: The effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumour. J. Nat. Cancer Inst. 82: 672-676, 1990.

153.      Chaplin, D.J., Trotter, M.J., Skov, K. and Horsman, M.R.: Modification of tumour radiation response in vivo by the benzamide analog pyrazinamide. Br. J. Cancer 62: 561-566, 1990.

154.      Christensen, K.L., Horsman, M.R. & Overgaard, J.: Invasive blood pressure measurements in restrained but non-anaesthetized mice. In Vivo. 4: 13-16, 1990.

155.      Damstrup, L., Andersen, J. & Poulsen, H.S.: Immunocytochemical assay for the estrogen-regulated proteins Mr 52,000 and Mr 24,000 in primary breast cancer: Correlation with estrogen receptor and response to endocrine therapy. Oncology (Life Science Advances) 9: 69-76, 1990.

156.      Frølich, A., Christensen, L. & Andersen, J.: Estrogen receptors appear undetecable in the C-cells of the human thyroid gland. Bone 11: 393-396, 1990.

157.       Gotthold, T: En undersøgelse af vækst og strålerespons i tumorer. M.S. thesis, Faculty of Natural Sciences, University of Aarhus, 1990.

158.      Grau, C., Bentzen, S.M. & Overgaard, J.: Cytotoxic effect of misonidazole and cyclophosphamide on aerobic and hypoxic cells in a C3H mammary carcinoma in vivo. Brit. J. Cancer: 61: 61-64, 1990.

159.      Grau, C. & Overgaard, J.: The influence of radiation dose on the magnitude and kinetics of reoxygenation in a C3H mammary carcinoma. Radiat. Res. 122: 309-315, 1990.

160.      Grau, C., Zachariae, C. Mao, H-S. & Overgaard, J.: The in vivo response of a C3H mammary carcinoma to treatment with misonidazole, cyclophosphamide and radiation. Acta Oncologica 29: 769-774, 1990.

161.      Hansen, P.V., Trykker, H., Svennekjær, I.L. & Hvolby, J.: Long-term recovery of spermatogenesis after radiotherapy in patients with testicular cancer.  Radiotherapy and Oncology 18: 117-125, 1990.

162.      Horsman, M.R., Chaplin, D.J. & Overgaard, J.: The combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumour cells. Cancer Res. 50: 7430-7436, 1990.

163.      Horsman, M.R., Wood, P.J., Chaplin, D.J. Brown, M.J. & Overgaard, J.: The potentiation of radiation damage by nicotinamide in the SCCVII tumour in vivo. Radiotherapy and Oncology 18: 49-57, 1990.

164.      Johansen, L.V., Overgaard, J., Hjelm-Hansen, M. & Gadeberg, C.C.: Primary radiotherapy of T1 squamous cell carcinoma of the larynx. Analysis of 478 patients treated from 1963 to 1985. Int. J. Radiation Oncology, Biol. Phys. 18: 1307-1313, 1990.

165.      Johansen, L.V., Overgaard, J., Overgaard, M., Birkler, N. & Fisker, A.: Squamous Cell Carcinoma of the Oropharynx. 213 patients treated by radiotherapy in the period 1959-85. Laryngoscope 100: 985-990, 1990.

166.      Langkilde, N.C., Wolf, H. & Ørntoft, T.F.: Lewis negative phenotype and bladder cancer. Lancet i: 926, 1990.

167.      Lindegaard, J.C. & Overgaard, J.: Step-down heating in a C3H mammary carcinoma in vivo: effects of varying the time and temperature of the sensitizing treatment. Int. J. Hyperthermia 6: 607-617, 1990.

168.      Lindegaard, J.C. & Nielsen, O.S.: Time-temperature relationships for L1A2 cells step-down heated from 38 to 45 EC in vitro. Radiation Research 121: 282-287, 1990.

169.      Marcussen, N.: Atubular glomeruli in cisplatin induced chronic interstitial nephropathy. An experimental sterological investigation. APMIS 98: 1087-1097, 1990.

170.      Matsui, M., Jingu, K., Masuda, K., Kamura, T., Tsukamoto, N., Matsuyama, T. & Overgaard, J: Radiation Enteri-tis: Mucosal regeneration and stromal reaction of the small intestine after irradiation. Jpn. J. Cancer Clin. 36: 2305-2312, 1990.

171.      Nielsen, O.S., Munro, A.J., Duncan, W., Sturgeon, J., Gospodarowics, M.K., Jewett, M.A.S., Malkin, A. & Thomas, G.M.: Is placental alkaline phosphatase (PLAP) a usefull marker for seminoma. Eur. J. Cancer 26: 1049-1054, 1990.

172.      Olsen, J.H., Winther, J. & de Nully Brown, P.: Risk for nonocular cancer in first-degree relatives of retinoblastoma patients. Hum. Genet. 85: 283-287, 1990.

173.      Overgaard, J.: The rationale for clinical trials. In: Practical aspects of clinical hyperthermia. Field, S.B. & Hand, J.W. (eds). Taylor and Francis, London & Philadelphia, pp. 213-241, 1990.

174.      Overgaard, J. & Bentzen, S.M.: Radiotherapy alone or combined with hyperthermia in the treatment of advanced malignant melanoma. In: Pigment Cell, Vol 10. Therapy of advanced  malignant melanoma. Rümke, P. (ed.), Karger, Basel, pp. 14-35, 1990.

175.      Overgaard, J. & Grau, C.: Interactions between bleomycin and X-irradiation. In: Antitumor drug-radiation interactions. Hill, B.T. & Bellamy, A.S. (eds.) CRC Press, Inc. pp. 53-67, 1990. 

176.      Overgaard, J. & Matsui, M.: Effect of radiation on glucose absorption in the mouse jejunum in vivo.. Radiotherapy and Oncology 18: 71-77, 1990.

177.      Overgaard, J., Zucali, R., Bentzen, S.M. & Kenda, R.: The role of radiotherapy in the treatment of melanoma. In: Cutaneous melanoma. Biology and management. Cascinelli, N., Santinama, M. & Veronesi, U. (eds.), Masson, Milan, pp. 257-272, 1990.

178.      Overgaard, M., Christensen, J. J., Johansen, H., Nybo-Rasmussen, A., Panduro, J., Laursen, F., Rose, C., van der Kooy, P., Gadeberg, C. C., Hjelm-Hansen, M., Kjær, M., J., Sørensen, N. E., Overgaard, J., West Andersen, K. & Zedeler, K.: Evaluation of radiotherapy in high-risk breast cancer patients. Report from the Danish Breast Cancer Cooperative Group (DBCG 82) trial. Int. J. Radiation Oncology, Biol. Phys. 19: 1121-1124, 1990.

179.      Reinhold, H.S. & Overgaard, J.: Hyperthermia in clinical oncology. Eur. J. Cancer 26: 915-916, 1990.

180.      Shinghal, A., Ørntoft, T.F., Nudelman, E., Nance, S., Schibig, L., Stroud, M.R., Clausen, H. & Hakomori, S.: Profiles of Lewisx-containing glycoproteins and glycolipids in sera of patients with adenocarcinoma. Cancer Res. 50: 1375-1380, 1990.

181.      Thames, H.D., Bentzen, S.M., Turesson, I, Overgaard, M. & van der Bogaert, W.: Time-dose factors in radiotherapy: A review of the human data. Radiotherapy and Oncology 19: 219-235, 1990.

182.      White, T., Mandel, U., Ørntoft, T.F., Dabelsteen, E., Karkov, J., Kubeja, M., Hakomori, S. & Clausen, H.: Murine monoclonal antibodies directed to the human histo-blood group A transferase and the presence therein of N-linked histo-blood group A determinant. Biochemistry 29: 2740-2747, 1990.

183.      Winther, J.: The effect of photodynamic therapy on a retinoblastoma-like tumour - an experimental in vitro and in vivo study on the poential use of photodynamic therapy in the treatment of retinoblastoma. (Dr. Med. Thesis, Medical Faculty, University of Aarhus). Acta Ophtalmol. 68: Suppl. 197, 1990.

184.      von der Maase, H.: Experimental drug-radiation interactions in critical normal tissues. In: Interactions between Antitumor Drugs and Radiation. Hill, B. & Bellamy, A. (eds.) CRC Press, Inc. pp. 191-205, 1990. 

185.      Ørntoft, T.F.: Expression and biosyntesis of ABH-related corbohydrate antigens in normal and pathologic human urothelium. (Dr. Med. Thesis, Medical Faculty, University of Aarhus). APMIS 98: Suppl. 17, 1990.

186.      Ørntoft, T.F., Harving, N. & Langkilde, N.C.: O-linked mucin type glycoproteins in normal and malignant colon mucosa: lack of T antigen expression and accumulation of Tn and sialosyl-Tn antigens in carcinomas. Int. J. Cancer 45: 666-672, 1990.